Related Experiment Video
Updated: Sep 15, 2025

03:14
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
Published on: December 6, 2024
691
Large language model integrations in cancer decision-making: a systematic review and meta-analysis.
Yuexing Hao1,2,3, Zhiwen Qiu4, Jason Holmes5
1Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA. yh727@cornell.edu.
NPJ Digital Medicine
|July 17, 2025
Summary
Large Language Models (LLMs) show promise in oncology decision-making, but current accuracy rates and evaluation methods highlight significant gaps. Further research is needed to ensure their safe and reliable clinical integration.
Area of Science:
- Oncology
- Artificial Intelligence
- Medical Informatics
Background:
- Large Language Models (LLMs) are increasingly utilized to aid cancer patients and clinicians in medical decision-making processes.
- The integration and evaluation of LLMs within the field of oncology represent a rapidly evolving area of research.
Purpose of the Study:
- To systematically review the integration of LLMs into oncology practice.
- To analyze how researchers evaluate the performance and utility of LLMs in cancer care.
Main Methods:
- A comprehensive literature search was conducted across major databases (PubMed, Web of Science, Scopus, ACM Digital Library) up to May 2024.
- Included studies spanned 15 different cancer types, with 56 studies selected for analysis.
- Meta-analysis was employed to synthesize quantitative findings on LLM performance.
Main Results:
- LLMs are frequently used for summarizing, translating, and communicating clinical information in oncology.
- Average overall accuracy of LLMs was 76.2%, with diagnostic accuracy averaging a lower 67.4%.
- Evaluations predominantly used quantitative data and automated metrics, focusing on accuracy and appropriateness, while neglecting safety, harm, and clarity.
Conclusions:
- Current LLM performance and evaluation methodologies indicate limitations for clinical readiness in cancer decision-making.
- Key challenges include limited domain knowledge and the necessity for human oversight.
- Standardized evaluation frameworks and open datasets are crucial for enhancing LLM reliability in oncology.
Related Concept Videos
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Mouse Models of Cancer Study
5.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K

